Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.41
Delayed Data
As of 10:25am ET
 -0.01 / -0.70%
Today’s Change
1.32
Today|||52-Week Range
2.16
-0.70%
Year-to-Date
Why Arena Pharmaceuticals Stock Sank in 2016
Jan 13 / MotleyFool.com - Paid Partner Content
Genocea Stock Up on Positive Genital Herpes Infections Data
Jan 06 / Zacks.com - Paid Partner Content
VIVUS Licenses Rights to PAH Drugs from Selten Pharma
Jan 11 / Zacks.com - Paid Partner Content
Arena, Eisai Modify Marketing & Supply Agreement for Belviq
Jan 05 / Zacks.com - Paid Partner Content
Puma (PBYI) Expands Study Cohort for Lead Candidate PB272
Jan 09 / Zacks.com - Paid Partner Content
Evoke Diabetic Gastroparesis Drug Gimoti Positive in Phase III
Jan 05 / Zacks.com - Paid Partner Content
Vertex Pharma Issues Disappointing 2017 Orkambi Outlook
Jan 09 / Zacks.com - Paid Partner Content
Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained
Jan 05 / Zacks.com - Paid Partner Content
Biogen Licenses Amunix's XTEN Technology for Factor IX Drug
Jan 06 / Zacks.com - Paid Partner Content
Bristol-Myers Extends Deal with Five Prime Therapeutics
Jan 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.42
Today’s open1.44
Day’s range1.40 - 1.45
Volume396,790
Average volume (3 months)1,699,249
Market cap$345.5M
Dividend yield--
Data as of 10:25am ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-60.71%
Earnings growth (this year)+26.34%
Earnings growth (next 5 years)-45.30%
Revenue growth (last year)+3.67%
P/E ratioNM
Price/Sales11.93
Price/Book6.44

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...0.000.00%
SVASinovac Biotech Ltd-0.04-0.67%
PRTKParatek Pharmaceutic...-0.47-3.07%
NLNKNewLink Genetics Cor...-0.58-4.83%
Data as of 10:38am ET, 01/17/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$38.3M
Annual profit (last year)-$108.0M
Net profit margin-281.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Amit D. Munshi
SVP-Operations &
Head-Global Regulatory Affairs
Craig M. Audet
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs